Trials / Completed
CompletedNCT01402128
Efficacy and Safety of Fermented Barley on Decrement of Body Fat in Obese Subjects
The Effect of Barley Beta-glucan on Serum Lipids and Body Weight
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Chonbuk National University Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Barley, like oats, is a rich source of the soluble fibre β-glucan, which has been shown to significantly lower LDL-cholesterol (LDL-C). However, barley foods have been less widely studied.
Detailed description
This study investigated whether the supplementation of barley β-glucan is reduce the visceral fat as well as the serum low-density lipoprotein cholesterol (LDL-C) and total cholesterol (TC) in mildly hypercholesterolemic subjects. In a 12 week double-blind, controlled study, subjects were randomized to one of treatment group(3.0g/day as β-glucan) or placebo group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Barley beta-glucan(3.0g) | Barley beta-glucan(3.0g/day) for 12 weeks |
| DIETARY_SUPPLEMENT | Placebo | Placebo for 12 weeks |
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2010-10-01
- Completion
- 2011-05-01
- First posted
- 2011-07-26
- Last updated
- 2012-12-25
- Results posted
- 2012-12-25
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01402128. Inclusion in this directory is not an endorsement.